Plantar, Ramel D.

HRN: 23-91-21  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/10/2024
CEFUROXIME 1.5GM (VIAL)
11/10/2024
11/17/2024
IV
1.5g
Q8
Nasofrontal Mass, For Elective OR
Waiting Final Action 
11/11/2024
MUPIROCIN 2%, 15G (TUBE)
11/11/2024
11/18/2024
TOPICAL
Topical
BID
S/p Excision Of Nasofrontal Cyst, Left
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: